Total Payments
$2,847
2023 Payments
$154.96
Companies
32
Transactions
163
Medicare Patients
529
Medicare Billing
$50,717
Payment Breakdown by Category
Food & Beverage$2,847 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,847 | 163 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $332.76 | 22 | $0 (2020) |
| Amgen Inc. | $328.99 | 20 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $325.26 | 19 | $0 (2020) |
| Gilead Sciences, Inc. | $163.51 | 14 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $158.65 | 10 | $0 (2020) |
| Inari Medical, Inc. | $154.96 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $154.90 | 7 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $123.81 | 7 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $111.66 | 8 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $108.75 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $154.96 | 1 | Inari Medical, Inc. ($154.96) |
| 2021 | $35.60 | 3 | Novo Nordisk Inc ($28.94) |
| 2020 | $207.58 | 14 | AstraZeneca Pharmaceuticals LP ($123.76) |
| 2019 | $695.98 | 39 | SANOFI-AVENTIS U.S. LLC ($138.66) |
| 2018 | $611.02 | 36 | SANOFI-AVENTIS U.S. LLC ($86.92) |
| 2017 | $1,142 | 70 | Amgen Inc. ($217.67) |
All Payment Transactions
163 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $154.96 | General |
| Category: VTE | ||||||
| 10/06/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Diabetes | ||||||
| 04/21/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Diabetes | ||||||
| 01/22/2021 | Clarus Therapeutics Inc. | JATENZO (Drug), JATENZO, JATENZO | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 10/28/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/18/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/17/2020 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/02/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $14.62 | General |
| Category: Cardiovascular | ||||||
| 02/13/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/10/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/29/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/21/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/09/2020 | Bardy Diagnostics, Inc. | Carnation Ambulatory Monitor (Device) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 12/09/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.15 | General |
| 11/20/2019 | Abbott Laboratories | Assurity Pacemaker (Device) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: DIABETES | ||||||
| 10/22/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $14.14 | General |
| Category: Cardiovascular | ||||||
| 10/17/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Cardiology | ||||||
| 10/16/2019 | Bardy Diagnostics, Inc. | Carnation Ambulatory Monitor (Device) | Food and Beverage | Cash or cash equivalent | $40.00 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/03/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 9 | 529 | 724 | $231,093 | $50,717 |
Total Patients
529
Total Services
724
Medicare Billing
$50,717
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 155 | 223 | $49,060 | $16,322 | 33.3% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2020 | 34 | 34 | $85,000 | $13,112 | 15.4% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 49 | 49 | $39,200 | $7,265 | 18.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2020 | 32 | 125 | $19,200 | $5,857 | 30.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 24 | 24 | $8,040 | $2,789 | 34.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 156 | 189 | $8,883 | $2,183 | 24.6% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2020 | 34 | 34 | $6,460 | $1,725 | 26.7% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2020 | 34 | 35 | $13,600 | $900.92 | 6.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 11 | $1,650 | $563.51 | 34.2% |
About Dr. Michael Mitchell, MD
Dr. Michael Mitchell, MD is a Nuclear Cardiology healthcare provider based in Arlington, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669436655.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Mitchell, MD has received a total of $2,847 in payments from pharmaceutical and medical device companies, with $154.96 received in 2023. These payments were reported across 163 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,847).
As a Medicare-enrolled provider, Mitchell has provided services to 529 Medicare beneficiaries, totaling 724 services with total Medicare billing of $50,717. Data is available for 1 year (2020–2020), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Cardiovascular Disease
- Location Arlington, TX
- Active Since 04/14/2006
- Last Updated 09/05/2019
- Taxonomy Code 207UN0901X
- Entity Type Individual
- NPI Number 1669436655
Products in Payments
- ENTRESTO (Drug) $315.61
- Corlanor (Drug) $264.51
- PRALUENT (Drug) $200.50
- FLOWTRIEVER CATHETER, S (Device) $154.96
- MULTAQ (Drug) $124.76
- FARXIGA (Drug) $123.76
- XARELTO (Drug) $111.66
- LifeVest (Device) $108.75
- PRALUENT ALIROCUMAB INJECTION (Biological) $99.14
- PRADAXA (Drug) $91.81
- ELIQUIS (Drug) $81.07
- CHANTIX (Drug) $80.83
- Lexiscan (Drug) $67.39
- Repatha (Biological) $64.48
- KYNAMRO (Drug) $58.87
- BRILINTA (Drug) $58.36
- PRALUENT (Biological) $55.76
- Carnation Ambulatory Monitor (Device) $55.00
- UPTRAVI (Drug) $46.93
- Edarbyclor (Drug) $45.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.